SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-291974
Filing Date
2020-11-13
Accepted
2020-11-12 21:18:02
Documents
15
Period of Report
2020-11-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d58713d8k.htm   iXBRL 8-K 27614
2 EX-1.1 d58713dex11.htm EX-1.1 158509
3 EX-5.1 d58713dex51.htm EX-5.1 12236
7 GRAPHIC g58713g1113023823072.jpg GRAPHIC 2935
  Complete submission text file 0001193125-20-291974.txt   374472

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA txmd-20201110.xsd EX-101.SCH 3076
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20201110_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20201110_pre.xml EX-101.PRE 11412
8 EXTRACTED XBRL INSTANCE DOCUMENT d58713d8k_htm.xml XML 3353
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 201308893
SIC: 2834 Pharmaceutical Preparations